Source: GlobeNewswire

Press Release: NeuroStar : Neuronetics Reports First Quarter 2019 Financial and Operating Results

MALVERN, Pa., May 07, 2019 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the first quarter of 2019.

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from NeuroStar's latest SEC filings

Annual Revenue

Based on data from NeuroStar's latest SEC filings


Christopher Thatcher's photo - President & CEO of NeuroStar

President & CEO

Christopher Thatcher

CEO Approval Rating


NeuroStar focuses on developing and commercializing non-invasive therapies for the treatment of chronic psychiatric and ... Read more